back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2023-05-24 15:03 Tx date 2023-05-18 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Milne, George M
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+8,733 vol |
78,733 | |
| Filed 2023-05-24 15:02 Tx date 2023-05-18 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Milne, George M
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
57 - Exercise of rights
|
-8,733 vol |
0 | |
| Filed 2023-03-07 10:44 Tx date 2023-03-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Milne, George M
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$178,283
+20,000 vol $8.91 each |
70,000 | |
| Filed 2022-05-23 11:30 Tx date 2022-05-18 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Milne, George M
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$167,307
+14,612 vol $11.45 each |
210,959 | |
| Filed 2022-05-23 11:29 Tx date 2022-05-18 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Milne, George M
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
56 - Grant of rights
|
+8,733 vol |
8,733 | |
| Filed 2022-05-23 11:28 Tx date 2017-05-08 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Milne, George M
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-03-08 16:42 Tx date 2022-03-04 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Milne, George M
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$54,100
+5,000 vol $10.82 each |
50,000 | |
| Filed 2021-06-17 16:50 Tx date 2021-06-14 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Milne, George M
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$403,122
+31,347 vol $12.86 each |
196,347 | |
| Filed 2021-03-09 13:28 Tx date 2021-03-05 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Milne, George M
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$65,000
+5,000 vol $13.00 each |
45,000 | |
| Filed 2020-12-21 18:59 Tx date 2020-12-21 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Milne, George M
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$262,076
+20,000 vol $13.10 each |
40,000 | |
| Filed 2020-06-16 11:53 Tx date 2020-06-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Milne, George M
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$472,500
+30,000 vol $15.75 each |
165,000 | |
| Filed 2020-06-03 14:31 Tx date 2020-06-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Milne, George M
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$642,300
+30,000 vol $21.41 each |
||
| Filed 2020-06-03 14:31 Tx date 2020-06-02 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Milne, George M
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$642,300
+30,000 vol $21.41 each |
165,000 | |
| Filed 2019-10-21 13:27 Tx date 2019-10-16 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Milne, George M
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$49,600
+10,000 vol $4.96 each |
20,000 | |
| Filed 2019-07-08 19:12 Tx date 2019-07-08 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Milne, George M
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$63,201
+10,000 vol $6.32 each |
10,000 | |
| Filed 2019-07-08 19:10 Tx date 2017-05-08 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Milne, George M
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-07-05 13:12 Tx date 2019-07-03 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Milne, George M
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$125,850
+15,000 vol $8.39 each |
135,000 | |
| Filed 2019-05-06 12:40 Tx date 2019-04-29 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Milne, George M
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$84,500
+10,000 vol $8.45 each |
120,000 | |
| Filed 2019-02-01 Tx date 2019-01-29 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Milne, George M
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$241,199
+30,000 vol $8.04 each |
110,000 | |
| Filed 2018-02-09 Tx date 2018-02-05 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Milne, George M
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$192,600
+30,000 vol $6.42 each |
80,000 | |
| Filed 2017-06-28 Tx date 2017-05-08 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Milne, George M
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-06-28 Tx date 2017-06-23 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Milne, George M
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+50,000 vol |
50,000 |